Clinical trial Recruiting at 1 site Interventional Ages 18 and up

Platelet-rich plasma for jaw fracture healing

Official title: Impact of Autologous Platelet-Rich Plasma on Promoting Bone Regeneration in Maxillary and Mandibular Fractures: A Randomized Controlled Trial

Run by CMH Lahore Medical College and Institute of Dentistry · NCT07930026 · Data updated 2026-11-12

This trial tests whether using a patient’s own PRP during jaw fracture surgery helps the upper or lower jaw bones heal faster and denser than surgery alone.

Quick facts

Study typeInterventional
Ages18 Years and up
SexAll
Enrollment40 (estimated)
SponsorCMH Lahore Medical College and Institute of Dentistry
Academic / other
Drugs / interventionschemotherapy
Locations2 sites (Lahore, Punjab Province and 1 other locations)
StatusRecruiting
StartedJune 2, 2026
Main results expectedNovember 13, 2026
Study endsDecember 11, 2026
Registry record updatedNovember 10, 2026
Trial IDNCT07930026 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Adults (18+) with maxillary or mandibular fractures requiring open reduction and internal fixation.

Probably not a fit

Patients with conditions that impair healing or those not benefiting from PRP may see no added bone healing advantage.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This randomized, parallel-group trial compares open reduction and internal fixation with titanium miniplates plus autologous PRP versus fixation without PRP in adults with maxillary or mandibular fractures. It uses a standardized protocol at a single center in Lahore, Pakistan, with follow-up through 6 months and CBCT-based assessment of bone healing. Eligible participants are adults 18 or older needing surgical fixation and able to attend follow-up visits. Outcomes focus on bone density at the fracture site and differences between maxillary and mandibular healing. The study aims to determine if PRP enhances bone regeneration in maxillofacial trauma beyond standard fixation.

Why it matters

Potential benefit: If successful, PRP could improve healing speed and bone quality after jaw fractures.

How similar studies have gone: Prior randomized trials have suggested higher bone density and faster healing with PRP in mandibular fractures, but evidence across maxillary fractures is limited and heterogeneous.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Age 18 years or older
* Fracture of the maxilla or mandible confirmed by clinical examination and panoramic radiograph
* Fracture requiring open reduction and internal fixation with titanium miniplates
* Willing and able to provide written informed consent and to attend all follow-up visits up to 6 months

Exclusion Criteria:

* Uncontrolled diabetes mellitus
* Bleeding or coagulation disorders (e.g., haemophilia, von Willebrand disease)
* Platelet disorders or thrombocytopenia
* Chronic renal failure
* Hepatic disease
* Active malignancy, or current chemotherapy or radiotherapy
* Osteoporosis or other metabolic bone disease
* Immunocompromised state (e.g., HIV/AIDS, long-term corticosteroid or immunosuppressive therapy)
* Current use of anticoagulant or antiplatelet medication
* Pregnancy or lactation
* Multiple or pathological fractures
* Refusal to provide informed consent

Where it's running

  • Institute of Dentistry; CMH Lahore Medical College
    Lahore, Punjab Province, Pakistan
    Recruiting
  • CMH Lahore
    Lahore, Pakistan
    Completed

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.